Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-22T05:18:13.807Z Has data issue: false hasContentIssue false
  • English
  • Français

Disability and quality of life in pure and comorbid social phobia. Findings from a controlled study

Published online by Cambridge University Press:  16 April 2020

H.U. Wittchen ,
M. Fuetsch ,
H. Sonntag ,
N. Müller  and
M. Liebowitz
H.U. Wittchen
Affiliation:
Max Planck Institute of Psychiatry, Clinical Psychology and Epidemiology Munich, Germany
M. Fuetsch
Affiliation:
Max Planck Institute of Psychiatry, Clinical Psychology and Epidemiology Munich, Germany
H. Sonntag
Affiliation:
Max Planck Institute of Psychiatry, Clinical Psychology and Epidemiology Munich, Germany
N. Müller
Affiliation:
Max Planck Institute of Psychiatry, Clinical Psychology and Epidemiology Munich, Germany
M. Liebowitz
Affiliation:
New York State Psychiatric Institute New York,NY, USA
Get access

Summary

Social phobia is increasingly recognized as a prevalent and socially impairing mental disorder. However, little data is available regarding the general and disease-specific impairments and disabilities associated with social phobia. Furthermore, most studies have not controlled for the confounding effects of comorbid conditions.

This study investigates: (a) the generic quality of life; (b) work productivity; and, (c) various other disorder-specific social impairments in current cases with pure (n = 65), comorbid (n = 51) and subthreshold (n = 34) DSM-IV social phobia as compared to controls with no social phobia (subjects with a history of herpes infections).

Social phobia cases reported a mean illness duration of 22.9 years with onset in childhood or adolescence. Current quality of life, as assessed by the SF-36, was significantly reduced in all social phobia groups, particularly in the scales measuring vitality, general health, mental health, role limitations due to emotional health, and social functioning. Comorbid cases revealed more severe reductions than pure and subthreshold social phobics. Findings from the Liebowitz self-rated disability scale indicated that: (a) social phobia affects most areas of life, but in particular education, career, and romantic relationship; (b) the presence of past and current comorbid conditions increases the frequency and severity of disease-specific impairments; and, (c) subthreshold social phobia revealed slightly lower overall impairments than comorbid social phobics. Past-week work productivity of social phobics was significantly diminished as indicated by: (a) a three-fold higher rate of unemployed cases; (b) elevated rates of work hours missed due to social phobia problems; and (c) a reduced work performance.

Overall, these findings underline that social phobia in our sample of adults, whether comorbid, subthreshold, or pure was a persisting and impairing condition, resulting in considerable subjective suffering and negative impact on work performance and social relationships. The current disabilities and impairments were usually less pronounced than in the past, presumably due to adaptive behaviors in life style of the respondents. Data also confirmed that social phobia is poorly recognized and rarely treated by the mental health system.

Keywords

comorbiditydisabilityquality of life
Type
Original article
Information
European Psychiatry , Volume 15 , Issue 1 , 2000 , pp. 46 - 58
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Wittchen, H.U.Stein, H.B.Kessler, R.C.Social fears and social phobia in a community sample of adolescents and young adults: prevalence, risk factors, and comorbidity. Psychol M 1999; 29: 309–323CrossRefGoogle Scholar
Angst, J.Vollrath, M.Merikangas, K.R.Ernst, C.Comorbidity of anxiety and depression in the Zurich cohort study of young adults.Maser, J.DCloninger, C.RComorbidity of mood and anxiety disorders. 1990 Washington DC: Am Psychiatr Press 123–153Google Scholar
Wittchen, H.U.Essau, C.A.Zerssen, D.VonKrieg, C.J.Zaudig, M.Lifetime and six-month prevalence of mental disorders in the Munich follow-up study. Eur Arch Psychiatry Clin Neurosci 1992; 241: 247–258CrossRefGoogle ScholarPubMed
Wacker, H.R.Müllejans, R.Klein, K.H.Battegay, R.Identification of cases of anxiety disorders and affective disorders in the community according to ICD-10 and DSM-III-R by using the composite international diagnostic interview (CIDI). Int J Meth Psychiatr Res 1992; 2: 91–100Google Scholar
Kessler, R.C.McGonagle, K.A.Zhao, S.Nelson, C.B.Hughes, M.Eshleman, S.Wittchen, H.U.Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National comorbidity survey. Arch Gen Psychiatry 1994; 51: 8–19CrossRefGoogle ScholarPubMed
Magee, W.J.Eaton, W.W.Wittchen, H.U.McGonagle, K.A.Kessler, R.C.Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 1996; 53: 159–168CrossRefGoogle ScholarPubMed
Davidson, J.R.Hughes, D.C.George, L.K.Blazer, D.G.The boundary of social phobia. Exploring the threshold. Arch Gen Psychiatry 1994; 51: 975–983CrossRefGoogle ScholarPubMed
Liebowitz, M.R.Gorman, J.M.Fyer, A.J.Klein, D.F.Social phobia: review of a neglected anxiety disorder. Arch Gen Psychiatry 1985; 42: 729–736CrossRefGoogle ScholarPubMed
Mullaney, J.A.Trippet, C.J.Alcohol dependence and phobias: clinical description and relevance. Br J Psychiatry 1979; 135: 565–573CrossRefGoogle ScholarPubMed
Borden, K.H.Social phobia: an overview of treatment strategies. J Clin Psychiatry 1993; 54: 165–171Google Scholar
Merikangas, K.Angst, J.Eaton, W.Canino, G.Rubio-Stipec, M.Wacker, H.Comorbidity and boundaries of affective disorders with anxiety disorders and substance abuse: results of an international task force. Br J Psychiatry 168 Suppl 30 1996 49–58CrossRefGoogle Scholar
World Health Organization. Composite International Diagnostic Interview (CIDI): a) CIDI-interview (version 1. 0), b) CIDI-user manual, c) CIDI-training manual, d) CIDI-computer programs. 1990 Geneva: World Health OrganizationGoogle Scholar
Wittchen, H.U.Semler, G.Composite international diagnostic interview (CIDI, version 1. 0). 1990 Weinheim: Beltz VerlagGoogle Scholar
Semler, G.Wittchen, H.U.Joschke, K.Zaudig, M.Geiso, T.Kaiser, S.Test-retest reliability of a standardized psychiatric interview (DIS/CIDI). Eur Arch Psychiatry Neuro Sci 1987; 236: 214–222CrossRefGoogle ScholarPubMed
Wittchen, H.U.Robins, L.N.Cottler, L.Sartorius, N.Burke, J.Regier, D.Cross-cultural feasibility, reliability and sources of variance of the composite international diagnostic interview (CIDI). Results of the multicenter WHO/ADAMHA field trials (wave I). Br J Psychiatry 1991; 159: 645–653CrossRefGoogle Scholar
Wittchen, H.U.Reliability and validity studies of the WHO-composite international diagnostic interview (CIDI): a critical review. J Psychiatr Res 1994; 28: 57–84CrossRefGoogle ScholarPubMed
Wittchen, H.U.Zhao, S.Abelson, J.M.Abelson, J.L.Kessler, R.C.Reliability and procedural validity of CIDI DSM-III-R phobic disorders. Psychol M in pressGoogle Scholar
Ware, J.E.Sherbourne, C.D.The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–483CrossRefGoogle ScholarPubMed
McHorney, C.A.Ware, J.E.Raczek, A.E.The MOS 36-item short form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247–263CrossRefGoogle ScholarPubMed
Brazier, J.E.Harper, R.Jones, N.M.O’Cathain, A.Thomas, K.J.Usherwood, T. et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J 1992; 305: 160–164CrossRefGoogle ScholarPubMed
McHorney, C.A.Ware, J.E.Rogers, W.Raczek, A.E.Lu, J.F.The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the medical outcomes study. Med Care 30 5 Suppl 1992 253–265CrossRefGoogle Scholar
Bullinger, M.Kirchberger, I.Ware, J. The German SF-36 health survey. Translation and psychometric testing of a generic instrument for the assessment of health-related quality of life unpublishGoogle Scholar
Schneier, F.R.Heckelman, L.R.Garfinkel, R.Campeas, R.Fallon, B.A.Gitow, A.Functional impairment of social phobia. J Clin Psychiatry 1994; 55: 322–331Google ScholarPubMed
Reilly, M.C.Zbrozek, A.S.Dukes, E.M.The validity and reproducibility of a work productivity and impairment instrument. PharmacoEconomics 1993; 4: 353–365CrossRefGoogle ScholarPubMed
Tarlov, A.R.Ware, J.E.Greenfield, S.The medical outcomes study: an application of methods for monitoring the results of medical care. JAMA 1989; 262: 925–930CrossRefGoogle ScholarPubMed
Schwerpunktbericht im Rahmen der Gesundheitsberichterstattung des Gesundheitsreferates der Landeshauptstadt München, München Jugend-Gesundheit. 1997Google Scholar
Weiller, I.Bisserbe, J.C.Bauer, P.Lepine, J.P.Lecrubier, Y.Social phobia in general health care. An unrecognized, untreated disabiliting disorder. Br J Psychiatry 1996; 168: 169–174CrossRefGoogle Scholar
Safren, S.A.Heimberg, R.G.Brown, E.J.Holle, C.Quality of life in social phobia. Depression Anxiety 1997; 4: 126–1333.0.CO;2-E>CrossRefGoogle Scholar
Kessler, R.C.Stang, P.Wittchen, H.U.Stein, M.Walters, E.E.Lifetime comorbidities between social phobia and mood disorders in the US national comorbidity survey. Psychol M 1999 in pressCrossRefGoogle ScholarPubMed
Wittchen, H.U.Beloch, E.The impact of social phobia on quality of life. Ont Clin Psychopharmacol 11 Suppl 3 1996 15–23CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.